CBD Life Sciences Inc. (OTCMKTS:CBDL) Short Interest Up 8,233.3% in November

CBD Life Sciences Inc. (OTCMKTS:CBDLGet Free Report) was the target of a large increase in short interest in November. As of November 30th, there was short interest totalling 100,000 shares, an increase of 8,233.3% from the November 15th total of 1,200 shares. Based on an average daily volume of 110,766,700 shares, the short-interest ratio is currently 0.0 days.

CBD Life Sciences Price Performance

Shares of CBDL remained flat at $0.00 during mid-day trading on Wednesday. 6,871,766 shares of the stock were exchanged, compared to its average volume of 13,246,205. CBD Life Sciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.03.

About CBD Life Sciences

(Get Free Report)

CBD Life Sciences Inc engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, and a line of pet products. The company is based in Scottsdale, Arizona.

See Also

Receive News & Ratings for CBD Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CBD Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.